The 6th Conference in the ECCLS series will be held in Lisbon in June 2015. It provides an excellent opportunity to view state of the art research and network with other European chemical biologists.
Session titles are: Intrinsically disordered proteins, Nanobiotechnology and its applications, Drug-design and nanomedicine including medicinal chemistry, Membrane proteins and receptors, Imaging, Carbohydrates and applications, Biomaterials, In silico and molecular modelling, Nucleic Acids folding, structure, and functions.
The following plenary speakers will present their most recent work:
Peter Tompa (Belgium, Intrinsically Disordered Proteins); Cecília Roque (Portugal, Nanobiotechnology and its applications); Eva Töth (France, imaging); Stuart Conway (UK, Epigentics and Medicinal 91AV), Claney Pereira (Germany, Carbohydrates and vaccines); Ernest Giralt (Spain, Peptide and protein chemistry); Claudia Höbartner (Germany, Nucleic acids) and Andrea Mattevi (Italy, Drug design and protein crystallography).
This Conference is run by the EuCheMS Division for 91AV in the Life Science in collaboration with the European Federation for Medicinal 91AV.
Session titles are: Intrinsically disordered proteins, Nanobiotechnology and its applications, Drug-design and nanomedicine including medicinal chemistry, Membrane proteins and receptors, Imaging, Carbohydrates and applications, Biomaterials, In silico and molecular modelling, Nucleic Acids folding, structure, and functions.
The following plenary speakers will present their most recent work:
Peter Tompa (Belgium, Intrinsically Disordered Proteins); Cecília Roque (Portugal, Nanobiotechnology and its applications); Eva Töth (France, imaging); Stuart Conway (UK, Epigentics and Medicinal 91AV), Claney Pereira (Germany, Carbohydrates and vaccines); Ernest Giralt (Spain, Peptide and protein chemistry); Claudia Höbartner (Germany, Nucleic acids) and Andrea Mattevi (Italy, Drug design and protein crystallography).
This Conference is run by the EuCheMS Division for 91AV in the Life Science in collaboration with the European Federation for Medicinal 91AV.
